Recent temporal trends in hospital costs for non-surgical patients receiving implantable cardioverter defibrillators

Na, Jonathan; Sokolow, Michael; Childress, James F.; Han, Paul K. J.; Patel, Sonika; Rottman, Jeffrey N.

doi:10.1007/s10840-021-00956-6

Cited by 3 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The last part of the procedure was a test of the implanted device. After the device pocket was closed, defibrillation threshold testing was performed by induction of ventricular fibrillation and delivery of at least 1 shock from the S-ICD [ 45 ]. Before the test, all the patients received propofol intravenously (i.v.)…”

Section: Methodsmentioning

confidence: 99%

Regional Anesthesia for the Implantation of a Subcutaneous Implantable Cardioverter-Defibrillator Using Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block

et al. 2023

View full text Add to dashboard Cite

Background The combination of pectoserratus plane block (PSP) and superficial serratus anterior plane block (S-SAP) was established to reduce the risk of general anesthesia for subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation in patients with high operative risk (American Society of Anesthesiologists [ASA] grade III or IV). This study compared outcomes from ultrasound-guided PSP and S-SAP in 16 patients requiring a subcutaneous implantable cardioverter-defibrillator (S-ICD) at a single center in Poland. Material/Methods A group of 16 patients with ASA grade III and IV qualified for S-ICD implantation was included. The pain assessment using numerical rating scale (NRS), patient’s comfort using Quality of Recovery-15 (QoR-15), the operator’s satisfaction using Operator’s Comfort Scale, adverse event occurrence, and the parameters’ stability were evaluated. Results The mean volume of the local anesthetics mixture of PSP block was 19.4 mL; S-SAP was 34.7 mL (mean total volume, 54.1 mL). The mean duration of the block was 21.3 min; the mean time of the S-ICD implantation was 108.4 min. Neither circulatory nor respiratory instability was observed. In 8 patients (50%), non-opioid analgesics were administered intraoperatively; in 11 patients (69%), fentanyl bolus ≤200 μg was administered. The intraoperative NRS score was low (max 2 points); NRS 24 h after the procedure was low (max 4 points). The mean value of QoR-15 was 133.9 points. Conclusions S-SAP combined with PSP is feasible and safe in providing anesthesia/analgesia during S-ICD implantation and showed good effects in a group of patients with high operative risk (ASA III or IV).

show abstract

Section: Methodsmentioning

confidence: 99%

Regional Anesthesia for the Implantation of a Subcutaneous Implantable Cardioverter-Defibrillator Using Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block

et al. 2023

View full text Add to dashboard Cite

show abstract

“…This trend has been reported for the costs of ICDs. Na et al conducted a single-center (U.S.) review of the costs associated with a hospitalization for ICD implantation that included encounters from 2015-2019 [161]. Cost analysis revealed a modest (− USD 1.82/day; p < 0.001) decrease in the supply costs of ICD implantation over this period.…”

Section: Future Economic Perspectivesmentioning

confidence: 99%

“…Cost analysis revealed a modest (− USD 1.82/day; p < 0.001) decrease in the supply costs of ICD implantation over this period. However, there was no significant decrease in the overall costs associated with these encounters, meaning that other costs were rising to offset improving supply costs [161]. Technological developments are progressing rapidly, and costs may not have time to drop with increasing adoption of new products.…”

Section: Future Economic Perspectivesmentioning

confidence: 99%

Paradigm Shifts in Cardiac Pacing: Where Have We Been and What Lies Ahead?

Ballantyne

Chew

Vandenberk

2023

JCM

View full text Add to dashboard Cite

The history of cardiac pacing dates back to the 1930s with externalized pacing and has evolved to incorporate transvenous, multi-lead, or even leadless devices. Annual implantation rates of cardiac implantable electronic devices have increased since the introduction of the implantable system, likely related to expanding indications, and increasing global life expectancy and aging demographics. Here, we summarize the relevant literature on cardiac pacing to demonstrate the enormous impact it has had within the field of cardiology. Further, we look forward to the future of cardiac pacing, including conduction system pacing and leadless pacing strategies.

show abstract

Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts

Philippon

Domain

Sarrazin

et al. 2022

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Recent temporal trends in hospital costs for non-surgical patients receiving implantable cardioverter defibrillators

Cited by 3 publications

References 11 publications

Regional Anesthesia for the Implantation of a Subcutaneous Implantable Cardioverter-Defibrillator Using Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block

Regional Anesthesia for the Implantation of a Subcutaneous Implantable Cardioverter-Defibrillator Using Pectoserratus Plane Block and Superficial Serratus Anterior Plane Block

Paradigm Shifts in Cardiac Pacing: Where Have We Been and What Lies Ahead?

Evolution of Devices to Prevent Sudden Cardiac Death: Contemporary Clinical Impacts

Contact Info

Product

Resources

About